To address the technology burden on sites, 7 of the top 20 biopharmas have adopted Veeva Site Connect, to simplify and standardize sponsor-site collaboration. Hear from Meghan Blair, director of regulatory affairs at Penn Medicine, how Veeva Site Connect improves site-sponsor collaboration and reduces the tech burden on sites.
Learn more about how Veeva Site Connect is helping top biopharmas improve site collaboration and improve trial outcomes for all.